Alan Hampson

4.4k total citations · 1 hit paper
74 papers, 2.6k citations indexed

About

Alan Hampson is a scholar working on Epidemiology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Hampson has authored 74 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 15 papers in Infectious Diseases and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Hampson's work include Influenza Virus Research Studies (63 papers), Respiratory viral infections research (37 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Alan Hampson is often cited by papers focused on Influenza Virus Research Studies (63 papers), Respiratory viral infections research (37 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Alan Hampson collaborates with scholars based in Australia, United States and Pakistan. Alan Hampson's co-authors include Gregory A. Tannock, Gordon Ada, Ian Barr, Jennifer L. McKimm‐Breschkin, Alexander Klimov, J. S. Mackenzie, Masato Tashiro, Aeron C. Hurt, Frederick G. Hayden and Alan Hay and has published in prestigious journals such as The Journal of Immunology, Diabetes Care and Clinical Infectious Diseases.

In The Last Decade

Alan Hampson

72 papers receiving 2.5k citations

Hit Papers

Options for the control of influenza III 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Hampson Australia 26 2.2k 573 515 414 337 74 2.6k
Olav Hungnes Norway 30 2.1k 1.0× 1.0k 1.8× 504 1.0× 509 1.2× 302 0.9× 86 3.0k
Rebecca Garten United States 29 2.3k 1.0× 708 1.2× 549 1.1× 343 0.8× 427 1.3× 56 2.6k
Angie Lackenby United Kingdom 28 2.9k 1.3× 863 1.5× 693 1.3× 577 1.4× 292 0.9× 52 3.3k
Helen L. Regnery United States 17 2.0k 0.9× 1.1k 1.9× 291 0.6× 366 0.9× 647 1.9× 21 2.6k
Matthew J. Memoli United States 29 1.6k 0.7× 997 1.7× 465 0.9× 548 1.3× 142 0.4× 53 2.6k
Henrietta Hall United States 17 2.6k 1.2× 973 1.7× 297 0.6× 392 0.9× 999 3.0× 25 2.9k
Teresa Wallis United States 12 1.6k 0.7× 373 0.7× 408 0.8× 297 0.7× 172 0.5× 15 1.7k
Sook‐San Wong United States 23 1.3k 0.6× 781 1.4× 359 0.7× 404 1.0× 280 0.8× 57 1.9k
Gregory A. Tannock Australia 21 1.3k 0.6× 553 1.0× 289 0.6× 377 0.9× 171 0.5× 69 1.8k

Countries citing papers authored by Alan Hampson

Since Specialization
Citations

This map shows the geographic impact of Alan Hampson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Hampson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Hampson more than expected).

Fields of papers citing papers by Alan Hampson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Hampson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Hampson. The network helps show where Alan Hampson may publish in the future.

Co-authorship network of co-authors of Alan Hampson

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Hampson. A scholar is included among the top collaborators of Alan Hampson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Hampson. Alan Hampson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kassianos, George, Ashis Banerjee, Alan Hampson, et al.. (2020). Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries. Drugs in Context. 9. 1–13. 17 indexed citations
2.
Tagg, John, Frank W. Austin, Terry Maguire, et al.. (2014). Volume 35 Number 3. Microbiology Australia. 35(3). 117–179.
3.
Hampson, Alan, Aisling O’Connor, & Albert Smolenski. (2012). Synaptotagmin‐like protein 4 and Rab8 interact and increase dense granule release in platelets. Journal of Thrombosis and Haemostasis. 11(1). 161–168. 29 indexed citations
4.
Hampson, Alan, Albert D. M. E. Osterhaus, Yuri Pervikov, & Marie Paule Kiény. (2006). Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6–7 December 2005. Vaccine. 24(23). 4897–4900. 8 indexed citations
5.
Hurt, Aeron C., Philip M. Hansbro, Björn Olsén, et al.. (2006). Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia. Archives of Virology. 151(11). 2301–2309. 39 indexed citations
6.
Barr, Ian, Naomi Komadina, Aeron C. Hurt, et al.. (2005). An influenza A(H3) reassortant was epidemic in Australia and New Zealand in 2003. Journal of Medical Virology. 76(3). 391–397. 24 indexed citations
7.
Ferson, Mark J, et al.. (2004). Concurrent Summer Influenza and Pertussis Outbreaks in a Nursing Home in Sydney, Australia. Infection Control and Hospital Epidemiology. 25(11). 962–966. 19 indexed citations
8.
Hurt, Aeron C., Jennifer L. McKimm‐Breschkin, Mandy McDonald, et al.. (2004). Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs. Virus Research. 103(1-2). 205–211. 23 indexed citations
9.
Hurt, Aeron C., Ian Barr, Naomi Komadina, & Alan Hampson. (2004). A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses. Virus Research. 103(1-2). 79–83. 6 indexed citations
10.
Barr, Ian, et al.. (2004). In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors. Antiviral Research. 63(3). 177–181. 21 indexed citations
11.
Osterhaus, Albert, Nancy J. Cox, & Alan Hampson. (2001). Options for the control of influenza IV : proceedings of the World Congress on Options for the Control of Influenza IV held in Crete, Greece, 23rd-28th September 2000. 2 indexed citations
12.
Gust, Ian D., Alan Hampson, & Daniel Lavanchy. (2001). Planning for the next pandemic of influenza. Reviews in Medical Virology. 11(1). 59–70. 30 indexed citations
13.
Gust, Ian D., et al.. (2000). Influenza activity - United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine.. MMWR Morbidity and Mortality Weekly Report. 49(17). 375–381. 32 indexed citations
14.
Hampson, Alan. (1999). Vaccination of the older adult: the Australian experience. Vaccine. 17. S63–S66. 5 indexed citations
15.
Hampson, Alan. (1999). Epidemiological data on influenza in Asian countries. Vaccine. 17. S19–S23. 51 indexed citations
16.
Ziegler, Thedi, Mark L. Hemphill, Alexander Klimov, et al.. (1999). Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A Viruses. The Journal of Infectious Diseases. 180(4). 935–939. 77 indexed citations
17.
Hampson, Alan. (1997). Surveillance for Pandemic Influenza. The Journal of Infectious Diseases. 176(s1). S8–S13. 24 indexed citations
18.
Brown, Lorena E., Alan Hampson, & Robert G. Webster. (1996). Options for the control of influenza III : proceedings of the third International Conference on Options for the Control of Influenza, Cairns, Australia, 4-9 May, 1996. Elsevier eBooks. 2 indexed citations
19.
Aymard, Michèle, Nancy J. Cox, C Hannoun, et al.. (1994). Recommendations of the 7th European Meeting of Influenza and Its Prevention. European Journal of Epidemiology. 10(4). 525–526. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026